Bordetella evolution: Lipid A and Toll-like receptor 4

Journal of Endotoxin Research

Volumn 13, Issue 4, 2007, Pages 243-247

  MacArthur, Iain ^a   Mann, Paul B ^b   Harvill, Eric T ^b   Preston, Andrew ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Bordetella; Evolution; Lipid A modification; Toll like receptor 4

Indexed keywords

LIPID A; PERTUSSIS TOXIN; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL GENOME; BORDETELLA BRONCHISEPTICA; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTOXEMIA; GENE EXPRESSION; GENE MUTATION; GENETIC CONSERVATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; PATHOGENICITY; PERTUSSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ARTICLE; BACTERIAL INFECTION; BORDETELLA; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE;

BORDETELLA; BORDETELLA BRONCHISEPTICA; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS;

BORDETELLA; BORDETELLA INFECTIONS; HUMANS; LIPID A; MODELS, MOLECULAR; SPECIES SPECIFICITY; TOLL-LIKE RECEPTOR 4;

EID: 35448937612     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/0968051907082609     Document Type: Conference Paper

References (42)

1. Cherry JD Pertussis - the trials and tribulations of old and new pertussis vaccines. Vaccine 1992; 10: 1033-1038.
2. Cherry JD Historical review of pertussis and the classical vaccine. J Infect Dis 1996; 174: S259-S263.
3. Heininger U., Stehr K., Schmittgrohe S. et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994; 13: 306 - 309.
4. Pichichero ME, Treanor J. Economic impact of pertussis. Arch Pediatr Adolesc Med 1997; 151: 35-40.
5. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275: 1672-1674.
6. Watanabe M., Nagai M. Whooping cough due to Bordetella parapertussis: An unresolved problem. Expert Rev Anti Infect Ther 2004; 2: 447-454.
7. Porter JF, Connor K., Donachie W. Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. Microbiology 1994; 140: 255 - 261.
8. Porter JF, Connor K., Donachie W. Differentiation between human and ovine isolates of Bordetella parapertussis using pulsed-field gel-electrophoresis. FEMS Microbiol Lett 1996; 135: 131-135.
9. Porter JF, Connor K., van der Zee A. et al. Characterization of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous hemagglutinin production, cellular fatty-acid composition and antibiotic-sensitivity. FEMS Microbiol Lett 1995; 132: 195-201.
10. van der Zee A., Mooi F., van Embden J., Musser J. Molecular evolution and host adaptation of Bordetella spp.: Phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J Bacteriol 1997; 179: 6609-6617.
11. Keil DJ, Fenwick B. Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs. J Am Vet Med Assoc 1998; 212: 200-207.
12. Speakman AJ, Dawson S., Binns SH, Gaskell CJ, Hart CA, Gaskell RM Bordetella bronchiseptica infection in the cat. J Small Anim Pract 1999; 40: 252-256.
13. Rutter JM Quantitative observations on Bordetella bronchiseptica infection in atrophic rhinitis of pigs. Vet Rec 1981; 108: 451-454.
14. Goodnow RA Biology of Bordetella bronchiseptica. Microbiol Rev 1980; 44: 722 - 738.
15. Cotter PA, Miller JF Bordetella. In: Groisman E. (ed) Principles of bacterial pathogenesis. San Diego, CA: Academic Press, 2001; 619-674.
16. Mallory FB, Horner AA Pertussis: The histological lesion in the respiratory tract. J Med Res 1912; XXVII: 115-123.
17. Lapin JH Whooping cough. Springfield, IL: Charles C. Thomas, 1943.
18. Mattoo S., Cherry JD Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18: 326 - 382.
19. Parkhill J., Sebaihia M., Preston A. et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003; 35: 32-40.
20. Preston A., Parkhill J., Maskell DJ The bordetellae: Lessons from genomics. Nat Rev Microbiol 2004; 2: 379-390.
21. Cummings CA, Brinig MM, Lepp PW, van de Pas S., Relman DA Bordetella species are distinguished by patterns of substantial gene loss and host adaptation. J Bacteriol 2004; 186: 1484-1492.
22. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 2005; 1: E45.
23. Bjornstad ON, Harvill ET Evolution and emergence of Bordetella in humans. Trends Microbiol 2005; 13: 355-359.
24. Grenfell BT Dynamics and epidemiological impact of microparasites. In: Smith GL. (ed) New challenges to health: The threat of virus infection. Cambridge: Cambridge University Press, 2001; 33-52.
25. Cone Jr TC Whooping cough is first described as a disease sui generis by Baillou in 1640. Pediatrics 1970; 46: 522.
26. Arico B., Rappuoli R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol 1987; 169: 2847-2853.
27. Carbonetti NH, Artamonova GV, Van Rooijen N, Ayala VI Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect Immun 2007; 75: 1713-1720.
28. Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 2005; 115: 3594-3601.
29. Mann PB, Kennett MJ, Harvill ET Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis 2004; 189: 833-836.
30. Mann PB, Elder KD, Kennett MJ, Harvill ET Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect Immun 2004; 72: 6650 - 6658.
31. Higgins SC, Lavelle EC, McCann C. et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 2003; 171: 3119-3127.
32. Mann PB, Wolfe D., Latz E., Golenbock D., Preston A., Harvill ET Comparative Toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun 2005; 73: 8144-8152.
33. Caroff M., Aussel L., Zarrouk H. et al. Structural variability and originality of the Bordetella endotoxins. J Endotoxin Res 2001; 7: 63-68.
34. Zarrouk H., Karibian D., Bodie S., Perry MB, Richards JC, Caroff M. Structural characterization of the lipids A of three Bordetella bronchiseptica strains: Variability of fatty acid substitution. J Bacteriol 1997; 179: 3756-3760.
35. Caroff M., Deprun C., Richards JC, Karibian D. Structural characterization of the lipid A of Bordetella pertussis 1414 endotoxin. J Bacteriol 1994; 176: 5156-5159.
36. Sweet CR, Preston A., Toland E. et al. Relaxed acyl chain specificity of Bordetella UDP-N-acetylglucosamine acyltransferases. J Biol Chem 2002; 277: 18281-18290.
37. Trent MS, Stead CM, Tran AX, Hankins JV Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res 2006; 12: 205-223.
38. Preston A., Maxim E., Toland E. et al. Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol 2003; 48: 725-736.
39. Pilione MR, Pishko EJ, Preston A., Maskell DJ, Harvill ET PagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun 2004; 72: 2837-2842.
40. Geurtsen J., Steeghs L., Hove JT, van der Ley P., Tommassen J. Dissemination of lipid a deacylases (PagL) among Gram-negative bacteria: identification of active-site histidine and serine residues. J Biol Chem 2005; 280: 8248-8259.
41. +/ alphaketoglutarate-dependent dioxygenase homologue. J Biol Chem 2000; 275: 32940-32949.
42. Geurtsen J., Steeghs L., Hamstra HJ et al. Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis. Infect Immun 2006; 74: 5574-5585.